HomeInsights52 Week High Stocks

Alembic Pharmaceuticals Ltd 52 Week High

Alembic Pharmaceuticals Ltd 52 Week High

stocks purchased

₹ 0.4 Cr

Volume Transacted

(Dec 27, 2024)

stocks purchased

3.7 K

Stocks Traded

(Dec 27, 2024)

Last Updated on: Dec 27, 2024

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

YEARHIGH

₹ 1296.15

Last updated on: Dec 26, 2024

Key Highlights

  • The 52 Week HIGH of Alembic Pharmaceuticals Ltd is ₹ 1296 as of 26 Dec 24 .

Company Fundamentals for Alembic Pharmaceuticals Ltd

No data available

Market Price of Alembic Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 20241037
24 Dec 20241036.3
23 Dec 20241044.6
20 Dec 20241055
19 Dec 20241050.15
18 Dec 20241056
17 Dec 20241035.75
16 Dec 20241054.6
13 Dec 20241061.35
12 Dec 20241046.45

Asset Value vs Market Value of Alembic Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharmaceuticals receives USFDA approval for Divalproex Sodium

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the U...

Read more

20 Dec 2024 18:30

News

Alembic Pharma gets USFDA nod for seizure treatment drug

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

20 Dec 2024 14:20

News

Alembic Pharma Panelav unit clears Brazil GMP audit

Alembic Pharmaceuticals has successfully completed the Brazilian Health Regulatory Agency ...

Read more

11 Dec 2024 12:39

News

Alembic Pharma receives USFDA's tentative approval for Olopatadine Hydrochloride Ophthalmic Solution

Alembic Pharmaceuticals announced that it has received Tentative Approval from the US Food...

Read more

04 Dec 2024 16:41

News

Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride eye drops

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

04 Dec 2024 14:54

News

Alembic Pharma Gujarat facility gets 5 observations from USFDA

The GMP inspection was conducted from 14 November 2024 to 22 November 2024. The USFDA issu...

Read more

25 Nov 2024 11:19

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Alembic Pharmaceuticals Ltd

What is the significance of Alembic Pharmaceuticals Ltd reaching its 52-week high?

Alembic Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Alembic Pharmaceuticals Ltd 52-week high?

Investors monitor Alembic Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Alembic Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Alembic Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Alembic Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Alembic Pharmaceuticals Ltd at its 52-week high?

Before investing in Alembic Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Alembic Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Alembic Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions